APPLICATION
ANDA217345
TYPE
ANDA
ORIGINAL APPROVAL
2025-10-24
LATEST ACTION
2025-10-24
ROUTE
INTRAVASCULAR, INTRAVENOUS
DOSAGE FORM
SOLUTION
MARKETING STATUS
Prescription
Products
ATROPINE SULFATEPrescription
ATROPINE SULFATE 1MG/ML (1MG/ML) · SOLUTION · INTRAVENOUS
ATROPINE SULFATEPrescription
ATROPINE SULFATE 0.4MG/ML (0.4MG/ML) · SOLUTION · INTRAVENOUS
Approval history
2025-10-24UNKNOWN · Original · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.